Centessa Pharmaceuticals Plc ADR (CNTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 50,811 | 44,242 | 105,156 | 383,221 | 395,026 |
| Marketable Securities | 195,403 | 206,482 | 179,349 | 98,956 | 123,423 |
| Receivables | 49,121 | 40,704 | 49,608 | 43,768 | 34,029 |
| TOTAL | $307,675 | $300,363 | $347,718 | $536,409 | $568,364 |
| Non-Current Assets | |||||
| PPE Net | 894 | 733 | 681 | 744 | 821 |
| Investments And Advances | 102,825 | 153,406 | 140,395 | 0 | 0 |
| Other Non-Current Assets | 36,906 | 37,625 | 39,051 | 39,645 | 40,530 |
| TOTAL | $140,625 | $191,764 | $180,127 | $40,389 | $41,351 |
| Total Assets | $448,300 | $492,127 | $527,845 | $576,798 | $609,715 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 8,683 | 5,692 | 5,132 | 7,143 | 7,443 |
| Accrued Expenses | 20,439 | 24,002 | 19,070 | 50,855 | 18,963 |
| TOTAL | $29,122 | $29,694 | $24,202 | $57,998 | $26,406 |
| Non-Current Liabilities | |||||
| Long Term Debt | 109,816 | 109,545 | 109,252 | 108,940 | 75,700 |
| Other Non-Current Liabilities | 7,788 | 7,969 | 8,144 | 8,315 | 8,472 |
| TOTAL | $117,604 | $117,514 | $117,396 | $117,255 | $84,172 |
| Total Liabilities | $146,726 | $147,208 | $141,598 | $175,253 | $110,578 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 134,448 | 134,073 | 133,619 | 133,184 | 131,846 |
| Common Shares | 364 | 363 | 362 | 359 | 357 |
| Retained earnings | -1,120,071 | -1,065,180 | -1,014,837 | -988,702 | -877,373 |
| Other shareholders' equity | 2,600 | 1,591 | 2,075 | 4,213 | 2,095 |
| TOTAL | $301,574 | $344,919 | $386,247 | $401,545 | $499,137 |
| Total Liabilities And Equity | $448,300 | $492,127 | $527,845 | $576,798 | $609,715 |